FDA clears TomTec’s new 2D Cardiac Performance Analysis MR software solution

NewsGuard 100/100 Score

TomTec Imaging Systems GmbH announces the FDA 510(k) clearance for its new 2D Cardiac Performance Analysis MR software solution.    

2D Cardiac Performance Analysis MR, in short 2D CPA MR, is a vendor independent software solution for the quantification of myocardial function with "cardiac MR cine images". 2D CPA MR presents a novel method to analyze myocardial deformation from routine CMR images, which have been acquired as part of a conventional cardiovascular MR examination - no time consuming tagging is necessary.

Based on innovative feature tracking technology, 2D CPA MR calculates regional and global velocity, displacement, strain, and strain-rate parameters.

With minimal user interaction, the manual trace of a single endocardial contour serves as initial pattern from which the system tracks the displacement of myocardial structures over the length of a complete heart cycle. The software tracks endo- and epicardium, and describes left ventricular deformation in terms of longitudinal, radial and circumferential components.

"2D CPA MR provides incremental information regarding left ventricular deformation and enhances the diagnostic possibilities. With 2D CPA MR, even a comprehensive strain analysis can be fully integrated into your clinical routine workflow" says Rolf Baumann TomTec's Vice President of Clinical Products and Innovations.    

Source:

TomTec

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revvity showcases cutting-edge solutions at SLAS2024